IS4730A - Aðferð til að búa til kamptóþesín afleiður - Google Patents

Aðferð til að búa til kamptóþesín afleiður

Info

Publication number
IS4730A
IS4730A IS4730A IS4730A IS4730A IS 4730 A IS4730 A IS 4730A IS 4730 A IS4730 A IS 4730A IS 4730 A IS4730 A IS 4730A IS 4730 A IS4730 A IS 4730A
Authority
IS
Iceland
Prior art keywords
pct
date
camptothecin derivatives
sec
formula
Prior art date
Application number
IS4730A
Other languages
English (en)
Other versions
IS2274B (is
Inventor
Gerard Fang Francis
Xie Shiping
Original Assignee
Osi Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osi Pharmaceuticals, Inc. filed Critical Osi Pharmaceuticals, Inc.
Publication of IS4730A publication Critical patent/IS4730A/is
Publication of IS2274B publication Critical patent/IS2274B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS4730A 1995-11-02 1998-04-29 Aðferð til að búa til kamptóþesín afleiður IS2274B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US613895P 1995-11-02 1995-11-02
PCT/US1996/017574 WO1997016454A1 (en) 1995-11-02 1996-11-01 Method for preparing camptothecin derivatives

Publications (2)

Publication Number Publication Date
IS4730A true IS4730A (is) 1998-04-29
IS2274B IS2274B (is) 2007-09-15

Family

ID=21719492

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4730A IS2274B (is) 1995-11-02 1998-04-29 Aðferð til að búa til kamptóþesín afleiður

Country Status (17)

Country Link
US (2) US6143891A (is)
EP (1) EP0876373B1 (is)
JP (1) JP3499246B2 (is)
AT (1) ATE301659T1 (is)
AU (1) AU717315B2 (is)
CA (1) CA2236420A1 (is)
CZ (1) CZ133898A3 (is)
DE (1) DE69635057T2 (is)
EA (1) EA001400B1 (is)
ES (1) ES2247606T3 (is)
HU (1) HUP9802407A3 (is)
IL (1) IL124287A (is)
IS (1) IS2274B (is)
NO (1) NO324308B1 (is)
NZ (1) NZ322318A (is)
PL (1) PL186540B1 (is)
WO (1) WO1997016454A1 (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491237A (en) * 1994-05-03 1996-02-13 Glaxo Wellcome Inc. Intermediates in pharmaceutical camptothecin preparation
US6716982B2 (en) 1995-11-02 2004-04-06 Osi Pharmaceuticals, Inc. Method for preparing camptothecin derivatives
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
AR035684A1 (es) 2001-02-21 2004-06-23 Yakult Honsha Kk Procedimiento para preparar 2'-amino-5'-hidroxipropiofenona, uso de la misma para la preparacion de analogos de camptotecina, procedimiento para prepararlos, compuestos intermediarios, procedimiento para preparar una cetona triciclica utilizada en la sintesis de analogos de camptotecina
WO2003068778A1 (en) * 2002-02-18 2003-08-21 Dr. Reddy's Laboratories Limited A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride
US6593334B1 (en) 2002-05-02 2003-07-15 The University Of North Carolina At Chapel Hill Camptothecin-taxoid conjugates as antimitotic and antitumor agents
US7067666B2 (en) * 2003-06-27 2006-06-27 Research Triangle Institute 7-substituted camptothecin and camptothecin analogs and methods for producing the same
JP5170741B2 (ja) 2004-04-27 2013-03-27 ウェルスタット バイオロジクス コーポレイション ウイルスおよびカンプトテシン類を使用する癌の処置
JP5190958B2 (ja) 2005-07-14 2013-04-24 ウェルスタット バイオロジクス コーポレイション ウイルス、フルオロピリミジンおよびカンプトテシンを使用した癌の処置
CN103288842B (zh) * 2012-02-24 2016-01-13 中国人民解放军第二军医大学 氟取代e环喜树碱类似物及其作为药物的用途
JP6877049B2 (ja) 2015-09-25 2021-05-26 ゼットワイ セラピューティクス インク．Ｚｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0555347A4 (en) * 1990-10-31 1995-01-11 Smithkline Beecham Corp Substituted indolizino 1,2-b)quinolinones
AU3611093A (en) * 1992-02-21 1993-09-13 Smithkline Beecham Corporation Substituted furo(3',4':6,7)indolizino(1,2-b)quinolinones

Also Published As

Publication number Publication date
EA001400B1 (ru) 2001-02-26
PL186540B1 (pl) 2004-01-30
ES2247606T3 (es) 2006-03-01
IS2274B (is) 2007-09-15
HUP9802407A3 (en) 2000-01-28
JP3499246B2 (ja) 2004-02-23
EP0876373A1 (en) 1998-11-11
EA199800354A1 (ru) 1999-02-25
US6284891B1 (en) 2001-09-04
CA2236420A1 (en) 1997-05-09
IL124287A (en) 2004-06-01
HUP9802407A1 (hu) 1999-04-28
DE69635057D1 (de) 2005-09-15
EP0876373B1 (en) 2005-08-10
AU717315B2 (en) 2000-03-23
JPH11515028A (ja) 1999-12-21
WO1997016454A1 (en) 1997-05-09
PL326869A1 (en) 1998-10-26
DE69635057T2 (de) 2006-06-01
CZ133898A3 (cs) 1998-08-12
NO981970D0 (no) 1998-04-30
NO981970L (no) 1998-06-30
NZ322318A (en) 2000-01-28
NO324308B1 (no) 2007-09-24
AU7603896A (en) 1997-05-22
ATE301659T1 (de) 2005-08-15
US6143891A (en) 2000-11-07

Similar Documents

Publication Publication Date Title
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
DE69711391D1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
DK0696281T3 (da) Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater
IL112622A (en) Iminoalkylamino or aminoalkylideneamino camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
IS2274B (is) Aðferð til að búa til kamptóþesín afleiður
ATE236139T1 (de) Verfahren zur herstellung von 2-chlor-5- chlomethyl-thiazol-derivaten
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
DE69414586D1 (de) Verfahren zur herstellung von indolizinderivaten
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
DE3483011D1 (de) Substituierte alkylamino-derivate von 6,11-dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel.
DK1070082T3 (da) Fremgangsmåde til fremstilling af 4,4-dimethyl-5alfa-cholesta-8,14,24-trien-3beta-ol og mellemprodukter i fremgangsmåden (I)